Dre Nuria Mederos

Médecin cadre hospitalier
Service d'oncologie médicale
Département d'oncologie UNIL CHUV

Contacter par mail
+41 79 556 7557

Specialisations

Oncologie thoracique

Domaines d'intérêt académique et/ou clinique

Oncologie thoracique et translationnelle

Publications scientifiques sélectionnées

2024

[Management of bone metastasis in non-small cell lung cancer].

Apeiranthiti A, Vanniere F, Bayoumy K, Christofis M, Serena A, Mosimann V, Abdelhamid K, Papadopoulos S, Nguyen-Ngoc T, Bouchaab H, Peters S, Mederos N

Rev Med Suisse. 2024 May 15;20(874):973-977

[Oncology: what's new in 2023].

Jankovic J, Abdelhamid K, Berthold D, Desbaillets N, Bouchaab H, Dei Tos G, Demicheli R, Diciolla A, Digklia A, Ferraro DA, Florez L, Galli-Vareia I, Hottinger A, Latifyan S, Liapi A, Mederos N, Giacomuzzi Moore B, Sakr R, Stamatiou A, Wagner AD, Peters S, Sarivalasis A, Vanniere F, Zaman K, Stravodimou A

Rev Med Suisse. 2024 Jan 17;20(856-7):80-87

2023

Testing a Model of Care for Patients on Immune Checkpoint Inhibitors Based on Electronic Patient-Reported Outcomes: Protocol for a Randomized Phase II Controlled Trial.

da Silva Lopes AM, Colomer-Lahiguera S, Darnac C, Giacomini S, Bugeia S, Gutknecht G, Spurrier-Bernard G, Cuendet M, Muet F, Aedo-Lopez V, Mederos N, Michielin O, Addeo A, Latifyan S, Eicher M

JMIR Res Protoc. 2023 Oct 18;12:e48386

Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors.

da Silva Lopes AM, Colomer-Lahiguera S, Darnac C, Giacomini S, Bugeia S, Gutknecht G, Spurrier-Bernard G, Aedo-Lopez V, Mederos N, Latifyan S, Addedo A, Michielin O, Eicher M

Support Care Cancer. 2023 Jul 22;31(8):484

[Salivary gland cancer: new therapeutic approaches].

Herrera Gomez RG, Mederos N, Szturz P, Degrauwe N, Jankovic J, Cristina V

Rev Med Suisse. 2023 May 17;19(827):958-963

[Oncology: what's new in 2022].

Nguyen-Ngoc T, Abdelhamid K, Degrauwe N, Galland S, Serena A, Christofis M, Mederos N, Bouchaab H, Diciolla A, Dris N, Orcurto A, Perrinjaquet C, Schnetz M, Latifyan S, Wetterwald L, Herrera Gómez RG, Cristina V, Sarivalasis A, Michielin O, Berthold D, Digklia A, Wagner AD, Zaman K, Peters S, Stravodimou A

Rev Med Suisse. 2023 Jan 18;19(N° 809-10):52-57

2022

[Management of brain metastases in 2022].

Schiappacasse L, Kinj R, De Micheli R, Mederos N, Tuleasca C, Cossu G, Dunet V, Levivier M, Bourhis J, Hottinger AF

Rev Med Suisse. 2022 May 18;18(782):976-983

[Targeted therapies and non-small cell carcinomas : novelties].

Stauber R, Gro S L, Nguyen-Ngoc T, Mederos N, Bouchaab H, Peters S, Abdelhamid K

Rev Med Suisse. 2022 May 18;18(782):970-975

[2021 Oncology update].

Meyer ML, Chrysou K, Stamatiou A, Gilabert M, Herrera Gomez RG, Latifyan S, Masmoudi S, Mederos N, Perrinjaquet C, Berthold D, Bouchaab H, Cristina V, Digklia A, Michielin O, Orcurto A, Sarivalasis A, Stravodimou A, Wagner AD, Zaman K, Peters S, Jankovic J

Rev Med Suisse. 2022 Feb 2;18(767):182-186

2021

Personalized Cytokine-Directed Therapy With Tocilizumab for Refractory Immune Checkpoint Inhibitor-Related Cholangiohepatitis.

Moi L, Bouchaab H, Mederos N, Nguyen-Ngoc T, Perreau M, Fenwick C, Vaucher J, Sempoux C, Peters S, Obeid M

J Thorac Oncol. 2021 Feb;16(2):318-326

2020

Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancer.

Mederos N, Friedlaender A, Peters S, Addeo A

ESMO Open. 2020 Nov;5(Suppl 4):e000796

[Small-cell lung cancer: management and novelties].

Abdelhamid K, Kakourou A, Degrauwe N, Nikolopoulou A, Bouchaab H, Peters S, Nguyen-Ngoc T, Mederos N

Rev Med Suisse. 2020 May 27;16(695):1079-1085

[Advances in Oncology 2019].

Vernadou A, Ferahta N, Mederos N, Ferraro D, Dischl-Antonioni I, Diciolla A, Liapi A, Mosimann V, Latifyan S, Aedo-Lopez V, Berthold D, Digklia A, Michielin O, Montemurro M, Wagner AD, Zaman K, Peters S, Stravodimou A, Sarivalasis A

Rev Med Suisse. 2020 Jan 15;16(676-7):72-77

2019

[The new management options for lung cancer in the immunotherapy era].

Meganem H, Socianu RM, Bouchaab H, Mederos N, Nguyen-Ngoc T, Peters S, Dolcan A

Rev Med Suisse. 2019 May 15;15(651):1032-1037

2018

[High grade serous ovarian cancer 2018 : advances and controversies].

Mederos N, Wolfer A, Mathevet P, Zaher M, Sarivalasis A

Rev Med Suisse. 2018 May 16;14(607):1037-1041

2011

mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patients.

Santarpia M, Magri I, Sanchez-Ronco M, Costa C, Molina-Vila MA, Gimenez-Capitan A, Bertran-Alamillo J, Mayo C, Benlloch S, Viteri S, Gasco A, Mederos N, Carcereny E, Taron M, Rosell R

J Transl Med. 2011 Sep 27;9:163

Predicting response to chemotherapy with early-stage lung cancer.

Rosell R, Taron M, Massuti B, Mederos N, Magri I, Santarpia M, Sanchez JM

Cancer J. 2011 Jan-Feb;17(1):49-56

2010

Cáncer no microcítico de pulmón localmente avanzado. Respuesta del tratamiento neoadyuvante en pacientes del INOR 2000-2008.

Collado JC., Areces F., Mederos N.

Revista de Oncología SOLCA. Julio-Diciembre 2010- Volumen 20, (3-4).

Education et formation

Société suisse d'oncologie médicale (SSOM) examen oral: 2015
Diplôme fédéral en médecine: 2015
European society for medical oncology (ESMO) examen théorique: 2014
Oncologie translationnelle et thoracique: 2011
Oncologie clinique: 2007
Médecine interne: 2000
Doctorat en médecine: 1994

Institutions de formation & expériences précédentes

Institut Universitari Dexeus (Barcelone)
Institut Català d'Oncologia (Barcelone)
National Institute of Oncology and Radiobiology (Havana)
Instituto Superior de Ciencias Medicas (Havana)

Langues parlées

Français, Anglais, Espagnol